List of health departments and ministries

FCC Holding Ukraine Fundraising Day on Wednesday, March 9

Retrieved on: 
Vendredi, mars 4, 2022
FCC, Student engagement, Student, Student center, Organization, Ministry, Gerald Ratner Athletics Center, Direct Relief, Friends, Food, Community college, Frederick Community College, Charity Navigator, List of health departments and ministries, Water, Medicine, Internet service provider, Life insurance, College, Child, Health

The day will also include an opportunity for the College community to come together for a moment of silence.

Key Points: 
  • The day will also include an opportunity for the College community to come together for a moment of silence.
  • "As we witness the unjust invasion of Ukraine by Russian forces, Frederick Community College stands in solidary and support of Ukraine and its people," said Dr. Thomas Powell, FCC interim president.
  • FCC students and employees are encouraged to share information about the FCC Ukraine Fundraising Day to family members and friends to maximize the impact of this effort.
  • If you have questions about the Ukraine Fundraising Day, you can contact Caroline Cole at [email protected] .

Tzu Chi Responds to the Developing Ukrainian Refugee Crisis

Retrieved on: 
Mercredi, mars 2, 2022
Tzu Chi, Heart, Compassion, Buddhism, List of health departments and ministries, Safety, Syrian civil war, SAN, Multimedia, Food, Medicine, Refugee, Education, Face, Pharmaceutical industry, Management

Reflecting on Tzu Chi's past support of people who are displaced, Powen Yen, the Chief Executive Officer of the Tzu Chi Charity Foundation, noted refugee crises extending from Syria and recently Afghanistan.

Key Points: 
  • Reflecting on Tzu Chi's past support of people who are displaced, Powen Yen, the Chief Executive Officer of the Tzu Chi Charity Foundation, noted refugee crises extending from Syria and recently Afghanistan.
  • Regardless, Tzu Chi USA calls on the public to contribute to our fundraiser, "Love & Compassion for Ukraine."
  • Donations are accepted in the following ways:
    by check: made payable to "Tzu Chi" and mailed to the Tzu Chi chapter nearest you.
  • The heart of Tzu Chi is embedded in its name: in Chinese, "tzu" means compassion and "chi," relief.

Direct Relief Mobilizing Emergency Aid for Ukraine

Retrieved on: 
Mardi, mars 1, 2022
Risk, Conditional sentence, Vomiting, Critical care, World War II, International Diabetes Federation, COVID-19, Accreditation, Hospital, WHO, IV, Diarrhea, Ministry, Society of Critical Care Medicine, List of health departments and ministries, Tourniquet, HIV, Medicine, Stroke, Safety, Bleeding, Sudden Attack, Norovirus, Tuberculosis, Multimedia, Oxygen, Polio, TB, Blood pressure, Critical Care Medicine (journal), HIV/AIDS, Zaporizhzhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine, Tranexamic acid, COVID, NGO, Direct Relief, Bandage, Society, Insulin, Medical device, Pharmaceutical industry, Vaccine, Health

Direct Relief is working to determine specific needs, secure requested medicines and supplies, and deliver the aid to people needing assistance, whether in Ukraine or across regional borders.

Key Points: 
  • Direct Relief is working to determine specific needs, secure requested medicines and supplies, and deliver the aid to people needing assistance, whether in Ukraine or across regional borders.
  • "Direct Relief was created out of the ashes of World War II by Europeans who fled," said Thomas Tighe, Direct Relief CEO and President.
  • Direct Relief is also in talks with medical manufacturers about securing and distributing supplies already in Ukraine, Poland and other nearby countries.
  • Since January 2021, Direct Relief has supplied Ukrainian healthcare providers with more than $27 million in medical aid.

CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021

Retrieved on: 
Mercredi, février 23, 2022
People, Acumen, PCR, Government, Raffles, Social Security, Ministry, COVID-19, Company, Collyer Quay, Dentist, UOB-Kay Hian, Research, Infection, City, Growth, Public expenditure, Sponsor, Percussion section, List of health departments and ministries, Sale, Environment, Consultant, Catalist, Vaccination, SGX, Efficiency, ART, NASDAQ, Polymerase chain reaction, Aoxin, Gemini, Sepsis, Patient, Exchange, Omicron, The Gemini, COVID-19 testing, Industry, Republic, Acquisition, Cancer, Income, Hospital, Health insurance, Pharmaceutical industry, Animal, Healthcare, Vaccine, Medical device, Dentistry, PRC, Group, Health, EBITDA

SINGAPORE, Feb 23, 2022 - (ACN Newswire) - Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021").

Key Points: 
  • SINGAPORE, Feb 23, 2022 - (ACN Newswire) - Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021").
  • However, Aoxin Q&M's dental services make it resilient and well-positioned ride out the current downturn to capitalize on strategic opportunities in the post-COVID healthcare sector".
  • We are keeping a close watch on the evolving COVID-19 situation in PRC, while managing our costs with strict discipline."
  • Revenue from primary healthcare segment increased by 19.7% from RMB78.5 million in FY2020 to RMB93.9 million in FY2021.

Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7%

Retrieved on: 
Mercredi, février 23, 2022
People, Acumen, See, PCR, COVID-19, Ministry, Company, Motherboard, Dentist, Bank, UOB-Kay Hian, Research, Bloodstream infections, Growth, The Group, Percussion section, List of health departments and ministries, Sale, Singapore Exchange, Catalist, Exercise, MOH, ART, Group, NASDAQ, Polymerase chain reaction, Aoxin, Gemini, Sepsis, Patient, Pneumonia, Omicron, The Gemini, COVID-19 testing, Artificial intelligence, Industry, PDF, Republic, Acquisition, ASEAN, Infection, Cancer, EBITDA, Hospital, Holding company, Health insurance, Pharmaceutical industry, Medical device, Dentistry, Vaccine, Animal, Tutoring, PRC, Health

Revenue from medical laboratory and dental equipment & supplies segment jumped by 304% to S$45.4 million.

Key Points: 
  • Revenue from medical laboratory and dental equipment & supplies segment jumped by 304% to S$45.4 million.
  • The Group's net profit after tax in FY2021 increased by 98% to S$39.4 million from the S$19.8 million recorded in FY2020.
  • PATMI (Profit after tax attributable to Shareholders excluding Minorities) grew by 55% to S$30.5 million, from S$19.7 million in the previous period.
  • As at 31 December 2021, the Group has 136 dental clinics as compared to 118 in 31 December 2020, an increase of 18.

Akebia Therapeutics Announces Amendment of License Agreement with Vifor Pharma in Preparation for Potential Vadadustat Launch

Retrieved on: 
Mardi, février 22, 2022
U.S. Securities and Exchange Commission, AKBA, Risk, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Altitude, European Medicines Agency, Collaboration, CKD, Lists of diseases, Dizziness, Tissue, Ministry, List of health departments and ministries, COVID-19, Therapy, Chronic kidney disease, Organization, Ministry of Health, Labour and Welfare, New Drug Application, Vadadustat, Review, Food, Adult, EPO, Vifor Pharma, Erythropoietin, Disease, Oxygen, License, PDUFA, Anemia, Dialysis, FDA, Fatigue, Nasdaq, Patient, Quality of life, NDA, Goal, Kidney disease, Private Securities Litigation Reform Act, Mortality, Pharmaceutical industry, Fine chemical, Akebia, Health

The new agreement further supports Akebia's commercialization strategy ahead of a potential first-in-class U.S. launch for vadadustat which, as previously noted, provides access to up to 60% of U.S. dialysis patients through existing Vifor Pharma relationships.

Key Points: 
  • The new agreement further supports Akebia's commercialization strategy ahead of a potential first-in-class U.S. launch for vadadustat which, as previously noted, provides access to up to 60% of U.S. dialysis patients through existing Vifor Pharma relationships.
  • The new agreement further expands this license to also include additional independent dialysis organizations.
  • In consideration for the extension of Vifor Pharma's customer group, Vifor Pharma agreed to an additional equity purchase of $20 million.
  • Under the terms of the amended and restated agreement, Vifor Pharma will accelerate payment of the previously agreed upon $25 million milestone to Akebia.

Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter

Retrieved on: 
Jeudi, février 10, 2022
Income, Medicare, Patient, SRT, GAAP, Company, Research, Vaccine, Proximity, Nasdaq, ROI, GLOBE, Technology, Method, EBITDA, Center, Insurance, General counsel, Radiation, FDA, Forgiveness, Sale, Ministry, Communication, Marketing, Physician, Optimism, Depreciation, American Academy, Growth, Conference call, Investment, Adjustment, Tax, COVID-19, Program, List of health departments and ministries, SensUs, Video game, Animal, Ridesharing company, Management, Pharmaceutical industry, Lithium, Real estate, Dermatology, Conference

BOCA RATON, Fla., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and 12 months ended December 31, 2021.

Key Points: 
  • Revenues for the fourth quarter of 2021 were $13.0 million, compared with $5.1 million for the fourth quarter of 2020.
  • Cost of sales for the fourth quarter of 2021 was $4.2 million, compared with $1.9 million for the prior-year quarter.
  • Selling and marketing expense for the fourth quarter of 2021 was $1.3 million, unchanged from the fourth quarter of 2020.
  • Adjusted EBITDA for the fourth quarter of 2021 was $5.6 million, compared with $1.3 million for the fourth quarter of 2020.

MNA Nurses and Healthcare Professionals Join Healthcare Watchdog and National Nurses United in Calling for the Creation of an Independent Presidential Federal COVID-19 Committee

Retrieved on: 
Lundi, février 7, 2022
White House, Government, 1999 Aggie Bonfire collapse, Policy, Pressure, Presidency of Donald Trump, Nursing, List of health departments and ministries, Senate, Letter, N95, Multimedia, Education, Legislature, Labour, Association, Infection, United States Senate, White House Coronavirus Task Force, COVID-19, Hospital, Patient, Public Health England, Severe acute respiratory syndrome coronavirus 2, Commonwealth, White, COVID, Trump administration political interference with science agencies, National Nurses United, Workplace, Pension, History, MNA, United States Senate Committee on Commerce, Science, and Transportation, Data collection, Vaccine, Central Laborers' Pension Fund v. Heinz, Emergency, NNU, Medicine, Insurance, Health

Our country's response to the COVID crisis has been reactive, lacking in transparency, and derailed by infighting and political divides."

Key Points: 
  • Our country's response to the COVID crisis has been reactive, lacking in transparency, and derailed by infighting and political divides."
  • For copies of the February 3 committee note and January 15 letters, email [email protected] .
  • National Nurses United, with more than 175,000 members nationwide, is the largest union and professional association of registered nurses in U.S. history.
  • Therefore, policy based solely on advising from federal employees is likely to be met with more resistance than policy formed by an independent committee.

Global Muscle Spasticity Market (2021 to 2028) - by Drug Type, Route of Administration, Distribution Channel and Region - ResearchAndMarkets.com

Retrieved on: 
Vendredi, février 4, 2022
Pharmaceutical, Health, Other Health, MHLW, Route of administration, Amyotrophic lateral sclerosis, Ministry, Occupational therapy, Spasticity, ALS, List of health departments and ministries, Diazepam, Neurotoxin, Muscle, Goal, MS, Sleep, Administration, Market share, Brain, Pain, Region, Baclofen, Common, Toxin (comics), Multiple sclerosis, Pharmaceutical industry, Health

The "Muscle Spasticity Market, by Drug Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Muscle Spasticity Market, by Drug Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • When muscles become stiff or contract, the condition is called as muscle spasticity.
  • Muscle spasticity is seen in a variety of conditions such as spinal cord injury, brain injury, diseases such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).
  • The increasing launches of new drugs and regulatory approvals for muscle spasticity are expected to drive the market growth during the forecast period.

Sputnik V vaccine granted full permanent approval in Russia

Retrieved on: 
Vendredi, février 4, 2022
Safety, List of health departments and ministries, Russian Direct Investment Fund, Coronavirus, Infection, COVID-19, Vaccination, Sputnik Light, Population, Pericarditis, V, Lazzaro Spallanzani National Institute for Infectious Diseases, Sputnik V COVID-19 vaccine, Vaccine, Immunoglobulin G, Equity, AstraZeneca, EUA, Myocarditis, Pharmaceutical industry, Omicron, Pfizer, RDIF

MOSCOW, Feb. 4, 2022 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces that the Russian Sputnik V vaccine against coronavirus has been granted full permanent approval by Russia's Health Ministry. It had previously held temporary emergency use authorization (EUA) from the Russian regulator.

Key Points: 
  • MOSCOW, Feb. 4, 2022 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces that the Russian Sputnik V vaccine against coronavirus has been granted full permanent approval by Russia's Health Ministry.
  • Sputnik V was authorized on August 11, 2020, becoming the world's first vaccine against COVID-19 to be granted emergency use authorization.
  • Sputnik V showed significantly smaller (2.6 times) reduction of virus neutralizing activity against Omicron as compared to reference Wuhan variant than Pfizer vaccine (8.1-fold reduction for Sputnik V in contrast to 21.4-fold reduction for Pfizer vaccine).
  • Sputnik Light is based on recombinant human adenovirus serotype number 26 (the first component of Sputnik V).